Related references
Note: Only part of the references are listed.Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A mendelian randomisation study
Fergus W. Hamilton et al.
PLOS MEDICINE (2023)
Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial
Antoine Roquilly et al.
INTENSIVE CARE MEDICINE (2023)
What's new in intensive care: disease tolerance
Rachel E. Powell et al.
INTENSIVE CARE MEDICINE (2023)
Hydrocortisone in Severe Community-Acquired Pneumonia
Pierre-Francois Dequin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Endothelial dysfunction and immunothrombosis in sepsis
Eleni Maneta et al.
FRONTIERS IN IMMUNOLOGY (2023)
Survival Benefits of Therapeutic Plasma Exchane in Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis
Olive P. E. Lee et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2023)
Tissue-specific reprogramming of glutamine metabolism maintains tolerance to sepsis
Brooks Leitner et al.
PLOS ONE (2023)
Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials
Jheng-Yan Wu et al.
CRITICAL CARE (2023)
Efficacy of CytoSorb®: a systematic review and meta-analysis
Soeren Becker et al.
CRITICAL CARE (2023)
Inflammatory biomarkers to predict the prognosis of acute bacterial and viral infections
Aline H. de Nooijer et al.
JOURNAL OF CRITICAL CARE (2023)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial
Charles-Herve Vacheron et al.
JOURNAL OF CRITICAL CARE (2023)
The outcome of IV vitamin C therapy in patients with sepsis or septic shock: a meta-analysis of randomized controlled trials
Baofang Liang et al.
CRITICAL CARE (2023)
Embracing complexity in sepsis
Alex R. R. Schuurman et al.
CRITICAL CARE (2023)
Molecular Patterns in Acute Pancreatitis Reflect Generalizable Endotypes of the Host Response to Systemic Injury in Humans
Lucile P. A. Neyton et al.
ANNALS OF SURGERY (2022)
Effect of Bone Marrow Mesenchymal Stromal Cell Therapies in Rodent Models of Sepsis: A Meta-Analysis
Lite Ge et al.
FRONTIERS IN IMMUNOLOGY (2022)
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol
Antigone Kotsaki et al.
BMJ OPEN (2022)
Sepsis, pyruvate, and mitochondria energy supply chain shortage
Charles E. McCall et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2022)
Immunopathophysiology of human sepsis
W. Joost Wiersinga et al.
EBIOMEDICINE (2022)
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19
Fotios Karagiannis et al.
NATURE (2022)
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit
Francois Lamontagne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial
Dirk van Lier et al.
FRONTIERS IN MEDICINE (2022)
Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial
Konstantinos Leventogiannis et al.
CELL REPORTS MEDICINE (2022)
Renaissance of glucocorticoids in critical care in the era of COVID-19: ten urging questions
Martin S. Winkler et al.
CRITICAL CARE (2022)
Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial
Eleni Karakike et al.
CRITICAL CARE (2022)
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial
Klaus Stahl et al.
CRITICAL CARE (2022)
Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
Andrea Sauer et al.
CRITICAL CARE (2022)
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
Antoine Monsel et al.
CRITICAL CARE (2022)
Tetracycline Antibiotics Induce Host-Dependent Disease Tolerance to Infection
Henrique G. Colaco et al.
IMMUNITY (2021)
A Peptide-Based Checkpoint Immunomodulator Alleviates Immune Dysfunction in Murine Polymicrobial Sepsis
Timothy W. Phares et al.
SHOCK (2021)
Adjuvant therapeutic plasma exchange in septic shock
Sascha David et al.
INTENSIVE CARE MEDICINE (2021)
The immunology of sepsis
Tom van der Poll et al.
IMMUNITY (2021)
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial
Pierre-Francois Laterre et al.
INTENSIVE CARE MEDICINE (2021)
High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial
Elena Garbero et al.
INTENSIVE CARE MEDICINE (2021)
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Laura Evans et al.
INTENSIVE CARE MEDICINE (2021)
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential
Ellen Gorman et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)
Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression
Margaret A. McBride et al.
FRONTIERS IN IMMUNOLOGY (2021)
Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury
Konrad Peukert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Identifying High-Risk Subphenotypes and Associated Harms From Delayed Antibiotic Orders and Delivery*
Xuan Han et al.
CRITICAL CARE MEDICINE (2021)
Case Report: Interferon- γ Rescues Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) Function in a COVID-19 Patient With ARDS and Superinfection With Multiple MDR 4MRGN Bacterial Strains
Clemens Grimm et al.
FRONTIERS IN IMMUNOLOGY (2021)
Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment
Andrea Sauer et al.
EUROPEAN RESPIRATORY REVIEW (2021)
The promise and perils of immunotherapy
Stefanie Lesch et al.
Blood Advances (2021)
Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock
Klaus Stahl et al.
INTENSIVE CARE MEDICINE EXPERIMENTAL (2021)
Combined glucocorticoid resistance and hyperlactatemia contributes to lethal shock in sepsis
Jolien Vandewalle et al.
CELL METABOLISM (2021)
Effect of IV High-Dose Vitamin C on Mortality in Patients With Sepsis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials*
Ryota Sato et al.
CRITICAL CARE MEDICINE (2021)
Cytokine adsorption in severe, refractory septic shock
Pedro David Wendel Garcia et al.
INTENSIVE CARE MEDICINE (2021)
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis
Manu Shankar-Hari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Swarm Learning for decentralized and confidential clinical machine learning
Stefanie Warnat-Herresthal et al.
NATURE (2021)
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Evdoxia Kyriazopoulou et al.
NATURE MEDICINE (2021)
Complement C5 inhibition protects against hemolytic anemia and acute kidney injury in anthrax peptidoglycan-induced sepsis in baboons
Ravi Shankar Keshari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies
Daisuke Kudo et al.
CRITICAL CARE (2021)
Pharmacokinetics, Pharmacodynamics, and Safety of Nivolumab in Patients With Sepsis-Induced Immunosuppression: A Multicenter, Open-Label Phase 1/2 Study
Eizo Watanabe et al.
SHOCK (2020)
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock The VITAMINS Randomized Clinical Trial
Tomoko Fujii et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study
Kristina E. Rudd et al.
LANCET (2020)
Immunotherapy in sepsis - brake or accelerate?
Folkert Steinhagen et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-γ in NK cells
Edy Y. Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis
Emanuele Valeriani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Efficacy of mesenchymal stem cell therapy for sepsis: a meta-analysis of preclinical studies
Xue-Yi Sun et al.
STEM CELL RESEARCH & THERAPY (2020)
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C. Angus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Spectral clustering of risk score trajectories stratifies sepsis patients by clinical outcome and interventions received
Ran Liu et al.
ELIFE (2020)
The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience
Philip D. Keith et al.
CRITICAL CARE (2020)
Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes
Guus P. Leijte et al.
CRITICAL CARE (2020)
Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients
Kenny Schlosser et al.
CRITICAL CARE MEDICINE (2019)
Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a post hoc analysis
Guillaume Geri et al.
INTENSIVE CARE MEDICINE (2019)
The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis
Jie Cui et al.
ANNALS OF INTENSIVE CARE (2019)
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
Christopher W. Seymour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy The SCARLET Randomized Clinical Trial
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
IFN-γ: A cytokine at the right time, is in the right place
J. Daniel Burke et al.
SEMINARS IN IMMUNOLOGY (2019)
Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial
Alpha A. Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series
Didier Payen et al.
BMC INFECTIOUS DISEASES (2019)
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
Richard S. Hotchkiss et al.
INTENSIVE CARE MEDICINE (2019)
Transcriptomic Signatures in Sepsis and a Differential Response to Steroids From the VANISH Randomized Trial
David B. Antcliffe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Identifying Novel Sepsis Subphenotypes Using Temperature Trajectories
Sivasubramanium Bhavani et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential
Takashi Ito et al.
CRITICAL CARE (2019)
Overview of the IL-1 family in innate inflammation and acquired immunity
Charles A. Dinarello
IMMUNOLOGICAL REVIEWS (2018)
Cellular Immunotherapy for Septic Shock A Phase I Clinical Trial
Lauralyn A. McIntyre et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration
Nuala J. Meyer et al.
CRITICAL CARE MEDICINE (2018)
Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters
Timothy E. Sweeney et al.
CRITICAL CARE MEDICINE (2018)
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q. Le et al.
ONCOLOGIST (2018)
Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: a phase 1 clinical trial
Xiao He et al.
TRANSLATIONAL RESEARCH (2018)
Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysis
Zhongheng Zhang et al.
CRITICAL CARE (2018)
Nivolumab plus interferon-γ in the treatment of intractable mucormycosis
David Grimaldi et al.
LANCET INFECTIOUS DISEASES (2017)
Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis
Ravi Shankar Keshari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
Andriani C. Patera et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial
Akiyoshi Hagiwara et al.
BMJ OPEN (2016)
Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction
Jose M. Condor et al.
STEM CELLS TRANSLATIONAL MEDICINE (2016)
Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
Emma E. Davenport et al.
LANCET RESPIRATORY MEDICINE (2016)
Developing a Clinically Feasible Personalized Medicine Approach to Pediatric Septic Shock
Hector R. Wong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis
Congcong Li et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Complement system part I - molecular mechanisms of activation and regulation
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis
Espen W. Skjeflo et al.
CRITICAL CARE (2015)
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series
Corine E. Delsing et al.
BMC INFECTIOUS DISEASES (2014)
Antibiotics regulate the immune response in both presence and absence of lipopolysaccharide through modulation of Toll-like receptors, cytokine production and phagocytosis in vitro
Christian Bode et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Anti-TNF-α therapy for patients with sepsis: a systematic meta-analysis
S. Lv et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis
J. F. Bermejo-Martin et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Tissue damage control in disease tolerance
Miguel P. Soares et al.
TRENDS IN IMMUNOLOGY (2014)
The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis
Emily Rimmer et al.
CRITICAL CARE (2014)
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
Katherine Chang et al.
CRITICAL CARE (2014)
Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis
Osamu Takasu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation
Jean-Louis Vincent et al.
CRITICAL CARE MEDICINE (2013)
Anthracyclines Induce DNA Damage Response-Mediated Protection against Severe Sepsis
Nuno Figueiredo et al.
IMMUNITY (2013)
An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis
Raymond J. g Langley et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Why Activated Protein C Was Not Successful in Severe Sepsis and Septic Shock: Are We Still Tilting at Windmills?
Peggy S. Lai et al.
CURRENT INFECTIOUS DISEASE REPORTS (2013)
Thrombosis as an intravascular effector of innate immunity
Bernd Engelmann et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial
Jianfeng Wu et al.
CRITICAL CARE (2013)
B and T lymphocyte attenuator expression on CD4(+) T-cells associates with sepsis and subsequent infections in ICU patients
Nicholas J. Shubin et al.
CRITICAL CARE (2013)
Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes
Anna Krasnodembskaya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Beneficial role of endogenous immunoglobulin subclasses and isotypes in septic shock
Eduardo Tamayo et al.
JOURNAL OF CRITICAL CARE (2012)
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Disease Tolerance as a Defense Strategy
Ruslan Medzhitov et al.
SCIENCE (2012)
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Jonathan S. Boomer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients
Caroline Guignant et al.
CRITICAL CARE (2011)
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
Lulong Bo et al.
CRITICAL CARE (2011)
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis
Robert Silasi-Mansat et al.
BLOOD (2010)
Toward a clinically feasible gene expression-based subclassification strategy for septic shock: Proof of concept
Hector R. Wong et al.
CRITICAL CARE MEDICINE (2010)
Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
Pavan Brahmamdam et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
Yan Zhang et al.
CRITICAL CARE (2010)
Granulocyte-Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression A Double-Blind, Randomized, Placebo-controlled Multicenter Trial
Christian Meisel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Identification of pediatric septic shock subclasses based on genome-wide expression profiling
Hector R. Wong et al.
BMC MEDICINE (2009)
Cellular Dysfunction in Sepsis
Mervyn Singer
CLINICS IN CHEST MEDICINE (2008)
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab1)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels
EA Panacek et al.
CRITICAL CARE MEDICINE (2004)
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
WC Aird
BLOOD (2003)
Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis
A Nierhaus et al.
INTENSIVE CARE MEDICINE (2003)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)